Hims & Hers Health is trading at €26.48, up 3.52%, amid a broader risk-on backdrop as U.S. growth stocks rally.
- The Nasdaq Composite is up 1.45%, while the S&P 500 is up 0.69%.
- Company-specific sentiment remains pressured by securities-law investigations and Visa scrutiny over weight-loss subscription chargebacks.
- Those negative headlines were reported previously and do not directly explain the August 27 gain.